Retention as director of Clinical Operations with compensation and an option grant (2022).
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Retention as director of Clinical Operations with compensation and an option grant (2022).
Retention as Director of Clinical Operations with compensation, bonus and an option grant (2023).
Compensation, bonus and option grant approved for Ms. Shallcross (2024 approval; option approved April 29, 2025).
Separation agreement after termination in workforce reduction, providing three months base salary, acceleration of unvested equity and extended option exercise period.
Loading...